Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken, Copenhagen, Denmark.
Eur J Pharm Biopharm. 2012 Jun;81(2):458-62. doi: 10.1016/j.ejpb.2012.03.007. Epub 2012 Mar 20.
The aim of the present study was to investigate the transport of γ-aminobutyric acid (GABA) across the basolateral membrane of intestinal cells. The proton-coupled amino acid transporter, hPAT1, mediates the influx of GABA and GABA mimetic drug substances such as vigabatrin and gaboxadol and the anticancer prodrug δ-aminolevulinic acid across the apical membrane of small intestinal enterocytes. Little is however known about the basolateral transport of these substances. We investigated basolateral transport of GABA in mature Caco-2 cell monolayers using isotope studies. Here we report that, at least two transporters seem to be involved in the basolateral transport of GABA. The basolateral uptake consisted of a high-affinity system with a K(m) of 290 μM and V(max) of 75 pmol cm(-2) min(-1) and a low affinity system with a K(m) of approximately 64 mM and V(max) of 1.6 nmol cm(-2) min(-1). The high-affinity transporter is Na(+) and Cl(-) dependent. The substrate specificity of the high-affinity transporter was further studied and Gly-Sar, Leucine, gaboxadol, sarcosine, lysine, betaine, 5-hydroxythryptophan, proline and glycine reduced the GABA uptake to approximately 44-70% of the GABA uptake in the absence of inhibitor. Other substances such as β-alanine, GABA, 5-aminovaleric acid, taurine and δ-aminolevulinic acid reduced the basolateral GABA uptake to 6-25% of the uptake in the absence of inhibitor. Our results indicate that the distance between the charged amino- and acid-groups is particular important for inhibition of basolateral GABA uptake. Thus, there seems to be a partial substrate overlap between the basolateral GABA transporter and hPAT1, which may prove important for understanding drug interactions at the level of intestinal transport.
本研究旨在探讨γ-氨基丁酸(GABA)在肠细胞基底外侧膜的转运。质子偶联氨基酸转运体 hPAT1 介导 GABA 及其类似物药物如 vigabatrin 和 gaboxadol 以及抗癌前体药物 δ-氨基乙酰丙酸穿过小肠上皮细胞的顶端膜进入细胞内。然而,对于这些物质的基底外侧转运知之甚少。我们使用同位素研究方法在成熟的 Caco-2 细胞单层中研究了 GABA 的基底外侧转运。在这里,我们报告说,至少有两种转运体似乎参与了 GABA 的基底外侧转运。GABA 的基底外侧摄取由高亲和力系统组成,K(m)为 290 μM,V(max)为 75 pmol cm(-2) min(-1),还有一个低亲和力系统,K(m)约为 64 mM,V(max)为 1.6 nmol cm(-2) min(-1)。高亲和力转运体依赖于 Na(+)和 Cl(-)。进一步研究了高亲和力转运体的底物特异性,Gly-Sar、亮氨酸、gaboxadol、肌氨酸、赖氨酸、甜菜碱、5-羟色氨酸、脯氨酸和甘氨酸将 GABA 摄取减少至无抑制剂时的 44-70%左右。其他物质,如 β-丙氨酸、GABA、5-氨基戊酸、牛磺酸和 δ-氨基乙酰丙酸,将基底外侧 GABA 摄取减少至无抑制剂时的 6-25%左右。我们的结果表明,带电荷的氨基和羧基之间的距离对于抑制基底外侧 GABA 摄取特别重要。因此,基底外侧 GABA 转运体和 hPAT1 之间似乎存在部分底物重叠,这对于理解肠道转运水平的药物相互作用可能很重要。